Design considerations to minimize the impact of drug absorption in polymer-based organ-on-a-chip platforms.
Ontology highlight
ABSTRACT: Biocompatible polymers, such as polydimethylsiloxane (PDMS), are the materials of choice for creating organ-on-a-chip microfluidic platforms. Desirable qualities include ease of fabrication, optical clarity, and hydrophobicity, the latter of which facilitates oxygen transport to encased cells. An emerging and important application of organ-on-a-chip technology is drug discovery; however, a potential issue for polymer-based microfluidic devices has been highlighted by recent studies with PDMS, which have demonstrated absorption (and thus loss) of hydrophobic drugs into PDMS under certain experimental conditions. Absorption of drug in the polymer can also lead to undesirable transfer of drug between adjacent microfluidic lines. Given the benefits of polymers, it is essential to develop a com
SUBMITTER: Shirure VS
PROVIDER: S-EPMC10597325 | biostudies-literature | 2017 Feb
REPOSITORIES: biostudies-literature
ACCESS DATA